2026-01-24 - Analysis Report
**Report for Tron (TRX-USD)**

### Company Overview
Tron is a blockchain-based platform that allows for the decentralized creation, trading, and storage of digital assets.

### Comparison of Return Rates

* Cumulative return of review stock: 971.49%
* Cumulative return of comparison stock (S&P 500, VOO): 107.98%
* Divergence: 863.50
* Relative divergence: 8.50%

The review stock has significantly outperformed the S&P 500 in cumulative return, with a divergence of 863.50 and a relative divergence of 8.50%.

### Alpha, Beta Analysis

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2018-2020  | -2351.0% | 85.9% | -2375.0% | 0.9 | 2.5B |
| 2019-2021  | 135.0% | 73.7% | 69.0% | 1.0 | 7.1B |
| 2020-2022  | 112.0% | 68.9% | 105.0% | 1.1 | 5.2B |
| 2021-2023  | 235.0% | 68.9% | 215.0% | 1.2 | 10.2B |
| 2022-2024  | 646.0% | 42.7% | 617.0% | 0.9 | 24.1B |
| 2023-2025  | 711.0% | 50.2% | 636.0% | 0.5 | 26.9B |

The review stock has shown varying levels of performance across different years, with positive and negative CAGR, MDD, Alpha, and Beta.

### Recent Stock Price Fluctuations

* Close: $0.30
* Last-market: 
  * Price: 0.29705334
  * Previous Close: 0.30499738
  * Change: -2.6%
* 5-day SMA: $0.30
* 20-day SMA: $0.30
* 60-day SMA: $0.29

The review stock has shown a recent decline in price, with a 5-day SMA and 20-day SMA coinciding at $0.30 and a 60-day SMA at $0.29.

### RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence

* Market Risk Indicator (MRI): 0.70
* RSI: 49.42
* PPO: -0.42
* Hybrid Signal: Buy (Cash 0%)
Risk Level: Medium (MRI 0.70)
* Recent (20 days) relative divergence change: -0.80 (-): worsening
* 7-day Rank change: 3 (+): rank up
* 7-day Dynamic Expected Return change: 264.80 (+): improving

The review stock has shown a medium risk level with a MRI of 0.70 and an RSI of 49.42, indicating a mixed signal. However, the PPO has shown a negative value, indicating a potential sell signal.

### Comprehensive Analysis Summary

The review stock has shown significant outperformance compared to the S&P 500 in cumulative return, with a divergence of 863.50 and a relative divergence of 8.50%. The review stock has shown varying levels of performance across different years, with positive and negative CAGR, MDD, Alpha, and Beta. The recent stock price fluctuations have shown a decline, with a 5-day SMA and 20-day SMA coinciding at $0.30 and a 60-day SMA at $0.29. The RSI and PPO index indicators have shown mixed signals, indicating a medium risk level. Recent news has highlighted the company's plans to increase adoption and utilization of its platform, potentially leading to future growth.

### Recent News & Significant Events

* 2025-08-10: From Theme Parks to Tron: This Company Wants to Be the MicroStrategy of TRX - Yahoo Finance
* 2026-01-18: TRX-USD Today: January 18 MetaMask Launches Native Tron Support - Meyka
* 2025-10-28: TRON Price Prediction 2025–2030 | Future Forecast - Capital.com
* 2026-01-17: TRON (TRX) Price Prediction 2026, 2027 – 2030: How High Can TRX Go? - Coinpedia Fintech News
* 2025-09-23: TRON (TRX) Price Today: TRX Live Price, Charts, News - Crypto.com
* 2025-09-18: Tron's 6x Premium To Its Underlying Crypto Token Value Seems Unjustified (NASDAQ:TRON) - Seeking Alpha

### Analyst Opinions

Analyst Consensus:
 

### Overall Conclusion

The review stock has shown significant outperformance compared to the S&P 500 and has mixed signals from the RSI and PPO index indicators. Recent news has highlighted the company's plans to increase adoption and utilization of its platform, potentially leading to future growth. However, the review stock has shown a decline in recent price movements, indicating caution.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.